Nuevocor, a Singapore-headquartered IND-stage biotechnology company developing cures for cardiomyopathies driven by aberrant mechanobiology, today announced the successful completion of US$45 million Series B financing.
Over the past three decades, EDBI and SEEDS have played a foundational role in advancing Singapore’s innovation economy — from anchoring global technology leaders to nurturing promising local startups.
SG Growth Capital Quarterly, April 2025 Read More »
VFlowTech, a homegrown leader in long-duration energy storage solutions, has successfully raised USD $20.5 million in its latest funding round.
Addepar, a leading global technology and data platform that investment professionals rely on to make the most informed, data-driven investment decisions, announced today the closing of its $230 million Series G investment round.
Addepar Raises $230 Million at $3.25 Billion Valuation in Series G Investment Round Read More »
Callio Therapeutics, a biotechnology company focused on realizing the promise of multi-payload antibody-drug conjugates (ADCs) to improve cancer therapy, today announced its launch with the closing of a $187.0 million Series A financing round.
Island, the Enterprise Browser company, announced the participation of EDBI, the strategic investment arm of the Singapore Economic Development Board, in its previously announced Series D funding round.
Subscribe to our quarterly e-Newsletter, The Upside to find out what’s shaping the future industries of Singapore and the region.
Investing in high-growth technologies that shape the future economic pillars of Singapore since 1991.
